title: Comparison of the BD GeneOhm VanR assay to culture for identification of vancomycin-resistant enterococci in rectal and stool specimens.
abstract: Active screening for vancomycin-resistant enterococci (VRE) in rectal and stool specimens has been recommended to limit the spread of antimicrobial resistance within certain high-risk populations. Directly from 502 rectal swabs and stool specimens, we evaluated the diagnostic performance of the BD GeneOhm VanR assay (BD GeneOhm, San Diego, CA), a rapid real-time PCR test that detects the presence of vanA and/or vanB genes. The VanR assay was compared to culture consisting of both bile-esculin-azide agar with 6 mug/ml vancomycin (BEAV agar) (BD Diagnostics, Sparks, MD) and BEAV broth with 8 mug/ml vancomycin (Hardy Diagnostics, Santa Maria, CA). Enterococci were identified to the species level using standard biochemical tests and a Phoenix automated microbiology system (BD Diagnostics, Sparks, MD). The susceptibility of the enterococci to vancomycin and teicoplanin was determined using an Etest (AB Biodisk, Solna, Sweden). VRE were initially isolated from 147 cultures, and the VanR assay detected 142 of the 147 positive cultures for a sensitivity of 96.6%. The specificity was 87.0% (309/355) largely due to false positives seen with the vanB portion of the assay. The sensitivity when testing rectal swabs was 98.3%, and the sensitivity for stool samples was 95.4% (P = 0.643). The specificity of rectal swabs was comparable to that of the stool specimens (87.5% and 86.5%, respectively). When used only to detect VanA resistance, the VanR assay was 94.4% (136/144) sensitive and 96.4% (345/358) specific, with positive and negative predictive values of 91.3% and 97.7%, respectively. In summary, the BD GeneOhm VanR assay is a good screening test for VRE in our population of predominantly vanA-colonized patients. However, patient samples testing only vanB positive should be confirmed by another method for the presence of VRE.
authors: Department of Pathology, The Johns Hopkins University, Baltimore, MD 21287, USA.
authors: Paul D
authors: PD
authors: Stamper
authors: Mian
authors: M
authors: Cai
authors: Clara
authors: C
authors: Lema
authors: Kim
authors: K
authors: Eskey
authors: Karen C
authors: KC
authors: Carroll
mesh_terms: D001426:Bacterial Proteins / Q000235:genetics*; D019729:Carbon-Oxygen Ligases / Q000235:genetics*; D016983:Enterococcus / Q000187:drug effects / Q000302:isolation & purification*; D005243:Feces / Q000382:microbiology*; D006801:Humans; D016133:Polymerase Chain Reaction / Q000379:methods*; D012007:Rectum / Q000382:microbiology*; D020713:Vancomycin Resistance
chemical_list: D001426:Bacterial Proteins; C071437:VanA ligase, Bacteria; C079913:VanB protein, Enterococcus; D019729:Carbon-Oxygen Ligases
references: Clin Chem. 2000 Mar;46(3):324-31
references: 10702518
references: Am J Infect Control. 2007 Mar;35(2):73-85
references: 17327185
references: Diagn Microbiol Infect Dis. 2001 Dec;41(4):215-20
references: 11777663
references: Infect Control Hosp Epidemiol. 2003 May;24(5):362-86
references: 12785411
references: J Clin Microbiol. 2003 Jun;41(6):2483-6
references: 12791869
references: J Clin Microbiol. 2003 Oct;41(10):4805-7
references: 14532226
references: Clin Infect Dis. 2004 Jan 1;38(1):78-85
references: 14679451
references: J Clin Microbiol. 2004 Apr;42(4):1637-40
references: 15071018
references: J Clin Microbiol. 2004 Jun;42(6):2636-43
references: 15184445
references: Clin Infect Dis. 2004 Aug 1;39(3):309-17
references: 15306996
references: Diagn Microbiol Infect Dis. 2004 Sep;50(1):59-69
references: 15380279
references: Antimicrob Agents Chemother. 1989 Sep;33(9):1588-91
references: 2554802
references: J Clin Microbiol. 1994 Dec;32(12):3072-4
references: 7883906
references: J Clin Microbiol. 1996 Aug;34(8):2042-4
references: 8818911
references: J Clin Microbiol. 1997 Aug;35(8):2026-30
references: 9230375
references: J Clin Microbiol. 1997 Sep;35(9):2325-30
references: 9276411
references: Emerg Infect Dis. 1997 Jul-Sep;3(3):311-7
references: 9284375
references: Diagn Microbiol Infect Dis. 1997 Sep;29(1):43-9
references: 9350415
references: Diagn Microbiol Infect Dis. 1997 Oct;29(2):95-102
references: 9368085
references: J Clin Microbiol. 1997 Dec;35(12):3166-70
references: 9399514
references: Antimicrob Agents Chemother. 2005 Jan;49(1):77-81
references: 15616278
references: J Infect Dis. 2005 Feb 15;191(4):588-95
references: 15655783
references: Clin Infect Dis. 2005 Aug 1;41(3):327-33
references: 16007529
references: Antimicrob Agents Chemother. 2005 Nov;49(11):4784-6
references: 16251331
references: Emerg Infect Dis. 2005 Oct;11(10):1539-44
references: 16318693
references: Clin Infect Dis. 2006 Jan 1;42 Suppl 1:S25-34
references: 16323116
references: Clin Infect Dis. 2006 Jan 15;42 Suppl 2:S82-9
references: 16355321
references: J Clin Microbiol. 2006 Apr;44(4):1578-80
references: 16597899
references: J Clin Microbiol. 2006 Jun;44(6):2072-7
references: 16757600
references: BMC Infect Dis. 2006;6:145
references: 17002792
references: J Infect Dis. 2007 Feb 1;195(3):314-7
references: 17205467
references: Clin Infect Dis. 2000 Mar;30(3):466-72
references: 10722429